Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance

• Biogen’s stock hit by soft sales of Alzheimer’s treatment

  Business - MarketWatch - October 30

• Bristol Myers’s stock pops as earnings top estimates and company raises guidance

  Business - MarketWatch - October 31

• Harley-Davidson’s stock falls as motorbike maker lowers guidance to reflect still-pressured consumer

  Business - MarketWatch - October 24

• Freshpet’s stock jumps premarket after earnings beat and company raises guidance

  Business - MarketWatch - November 4

• Reddit’s stock soars after social-media platform turns a profit, beats Q3 sales and earnings estimates

  Business - MarketWatch - October 30

• Pfizer’s earnings crush estimates as company raises guidance

  Business - MarketWatch - October 29

• Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance

  Business - MarketWatch - October 25

More from MarketWatch

• Analysts don’t budge on Williams-Sonoma ratings despite stock rally

  Business - MarketWatch - 11 minutes ago

• Is higher inflation here to stay? Fed faces hurdles in quest to crush rising prices.

  Business - MarketWatch - 20 minutes ago

• Treasury yields steady as traders weigh increased Russia-Ukraine tensions

  Business - MarketWatch - 21 minutes ago

• Philadelphia Fed’s manufacturing gauge shows activity contracted in November

  Business - MarketWatch - 27 minutes ago

• MicroStrategy’s stock could do something it hasn’t done in 24 years as bitcoin surges

  Business - MarketWatch - 40 minutes ago